Status:

COMPLETED

Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia

Lead Sponsor:

Gruppo Italiano Malattie EMatologiche dell'Adulto

Conditions:

Leukemia

Eligibility:

All Genders

Up to 60 years

Phase:

PHASE2

Brief Summary

RATIONALE: Drugs used in chemotherapy, such as fludarabine and cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividin...

Detailed Description

OBJECTIVES: Primary * Determine the antitumor activity of induction therapy comprising fludarabine phosphate with either alemtuzumab or cyclophosphamide followed by peripheral blood stem cell transp...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Diagnosis of chronic lymphocytic leukemia (CLL)
  • Advanced or progressive disease with ≥ 2 active clinical signs
  • PATIENT CHARACTERISTICS:
  • Fertile patients must use adequate contraception
  • No positive Coomb's test with signs of hemolysis
  • No active infection
  • No uncontrolled severe disease
  • No known hypersensitivity or anaphylactic reactions to murine antibodies or proteins
  • No other malignancies within the past 2 years except for adequately treated malignancies
  • No significant traumatic injury within the past 4 weeks
  • No coexisting medical or psychological condition that would limit study compliance
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics
  • No prior treatment for CLL
  • No major surgery within the past 4 weeks
  • No prior chemotherapy

Exclusion

    Key Trial Info

    Start Date :

    May 1 2007

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2011

    Estimated Enrollment :

    86 Patients enrolled

    Trial Details

    Trial ID

    NCT00462332

    Start Date

    May 1 2007

    End Date

    June 1 2011

    Last Update

    September 6 2013

    Active Locations (23)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 6 (23 locations)

    1

    S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo

    Alessandria, Italy

    2

    Universita Degli Studi di Bari

    Bari, Italy, 70124

    3

    Universita Cattolica del Sacro Cuore - Campobasso

    Campobasso, Italy, 86100

    4

    Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto"

    Catania, Italy, 95124

    Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia | DecenTrialz